XDH: Xanthine dehydrogenase/oxidase
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Key enzyme in purine degradation.
- Drugs that act on it: 5
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Febuxostat | Approved | Xanthine dehydrogenase inhibitor | Inhibitor | Boxed warning |
| Allopurinol | — | Xanthine dehydrogenase inhibitor | Inhibitor | Boxed warning |
| Bendazac | — | Xanthine dehydrogenase inhibitor | Inhibitor | Withdrawn |
| Oxypurinol | — | Xanthine dehydrogenase inhibitor | Inhibitor | — |
| Topiroxostat | — | Xanthine dehydrogenase inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Xanthinuria type I
- 0.73
- Gout
- 0.70
- Hyperuricemia
- 0.61
- Leukemia
- 0.60
- Lymphoma
- 0.60
- Xanthinuria type II
- 0.56
- Cancer
- 0.41
- Myalgia
- 0.37
- Eye inflammation
- 0.37
- Arthralgia
- 0.37
- Heart failure
- 0.35
- Hypertensive disorder
- 0.34
Drugs and mechanisms are from ChEMBL CHEMBL1929 (CC BY-SA 3.0). Gene name, function (UniProt P47989, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets